Fusion Pharmaceuticals Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Fusion Pharmaceuticals Inc. | FUSN - NASDAQ |
$14.00-$16.00 | $17.00 | $18.50 | 12.5 million | 6/26/2020 |
| Morgan Stanley, Jefferies, Cowen | ||||||
Co-Manager(s): Wedbush PacGrow | ||||||
| Health Care | ||||||
Filing(s): Filed 2020-06-05 Terms Added 2020-06-22 Terms Changed 2020-06-24 | ||||||
Fusion Pharmaceuticals Inc. Quote & Chart - Click for current quote - FUSN
IPO Boutique aggregates information on public companies and private companies, such as "FUSN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Fusion Pharmaceuticals Inc. (adapted from Fusion Pharmaceuticals Inc. prospectus):
They are a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "FUSN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.